Accu-Chek Guide and Accu-Chek Performa blood glucose meters 14 November 2019 Product defect correction – risk of delayed therapy due to potential battery issues Consumers and healthcare professionals are advised that Roche Diabetes Care Australia, in consultation with the Therapeutic Goods Administration (TGA), is undertaking a product defect correction for Accu-Chek Guide and Accu-Chek Performa blood glucose meters. Accu-Chek Guide and Accu-Chek Performa blood glucose meters are used by people with diabetes to monitor their blood glucose (also known as blood sugar) levels. These meters are supplied individually and also in a meter kit. Please visit www.accu-chek.com.au for more information. The TGA Safety Advisory can be found at: https://www.tga.gov.au/alert/accu-chek-guide-and-accu-chek-performa-blood-glucose-meters
News 12 December 2024 Expanded access to cheaper medicines for Australians living with type 2 diabetes Diabetes Australia thanks the Albanese Government for its decision to expand the Pharmaceutical Benefits Scheme (PBS) listings for Forxiga® and... Continue Reading
News 12 December 2024 Overweight and obesity overtakes smoking as leading health risk Being overweight and obese is now risking more Australians’ health than smoking according to new data, as a new government... Continue Reading
News 6 December 2024 Diabetes health professionals and researchers unite for tech on their way to the IDF World Diabetes Congress At the Australasian Diabetes Congress (ADC) in August this year, we asked diabetes health professionals and researchers to UNITE FOR... Continue Reading